158 related articles for article (PubMed ID: 27753535)
1. Estrogen induces RAD51C expression and localization to sites of DNA damage.
Alayev A; Salamon RS; Manna S; Schwartz NS; Berman AY; Holz MK
Cell Cycle; 2016 Dec; 15(23):3230-3239. PubMed ID: 27753535
[TBL] [Abstract][Full Text] [Related]
2. Estrogen receptor α-mediated transcription induces cell cycle-dependent DNA double-strand breaks.
Williamson LM; Lees-Miller SP
Carcinogenesis; 2011 Mar; 32(3):279-85. PubMed ID: 21112959
[TBL] [Abstract][Full Text] [Related]
3. Interplay between human DNA repair proteins at a unique double-strand break in vivo.
Rodrigue A; Lafrance M; Gauthier MC; McDonald D; Hendzel M; West SC; Jasin M; Masson JY
EMBO J; 2006 Jan; 25(1):222-31. PubMed ID: 16395335
[TBL] [Abstract][Full Text] [Related]
4. RAD51C: a novel cancer susceptibility gene is linked to Fanconi anemia and breast cancer.
Somyajit K; Subramanya S; Nagaraju G
Carcinogenesis; 2010 Dec; 31(12):2031-8. PubMed ID: 20952512
[TBL] [Abstract][Full Text] [Related]
5. Interaction of the double-strand break repair kinase DNA-PK and estrogen receptor-alpha.
Medunjanin S; Weinert S; Schmeisser A; Mayer D; Braun-Dullaeus RC
Mol Biol Cell; 2010 May; 21(9):1620-8. PubMed ID: 20219974
[TBL] [Abstract][Full Text] [Related]
6. Non-classical estrogen signaling in ovarian cancer improves chemo-sensitivity and patients outcome.
Hao D; Li J; Wang J; Meng Y; Zhao Z; Zhang C; Miao K; Deng C; Tsang BK; Wang L; Di LJ
Theranostics; 2019; 9(13):3952-3965. PubMed ID: 31281524
[TBL] [Abstract][Full Text] [Related]
7. The Interplay between the Cellular Response to DNA Double-Strand Breaks and Estrogen.
Yedidia-Aryeh L; Goldberg M
Cells; 2022 Oct; 11(19):. PubMed ID: 36231059
[TBL] [Abstract][Full Text] [Related]
8. Enhanced non-homologous end joining contributes toward synthetic lethality of pathological RAD51C mutants with poly (ADP-ribose) polymerase.
Somyajit K; Mishra A; Jameei A; Nagaraju G
Carcinogenesis; 2015 Jan; 36(1):13-24. PubMed ID: 25292178
[TBL] [Abstract][Full Text] [Related]
9. BRCA2 regulates homologous recombination in response to DNA damage: implications for genome stability and carcinogenesis.
Abaji C; Cousineau I; Belmaaza A
Cancer Res; 2005 May; 65(10):4117-25. PubMed ID: 15899802
[TBL] [Abstract][Full Text] [Related]
10. Combined Tumor Sequencing and Case-Control Analyses of RAD51C in Breast Cancer.
Li N; McInerny S; Zethoven M; Cheasley D; Lim BWX; Rowley SM; Devereux L; Grewal N; Ahmadloo S; Byrne D; Lee JEA; Li J; Fox SB; John T; Antill Y; Gorringe KL; James PA; Campbell IG
J Natl Cancer Inst; 2019 Dec; 111(12):1332-1338. PubMed ID: 30949688
[TBL] [Abstract][Full Text] [Related]
11. From the Cover: Location analysis of estrogen receptor alpha target promoters reveals that FOXA1 defines a domain of the estrogen response.
Laganière J; Deblois G; Lefebvre C; Bataille AR; Robert F; Giguère V
Proc Natl Acad Sci U S A; 2005 Aug; 102(33):11651-6. PubMed ID: 16087863
[TBL] [Abstract][Full Text] [Related]
12. BRCA1 regulates RAD51 function in response to DNA damage and suppresses spontaneous sister chromatid replication slippage: implications for sister chromatid cohesion, genome stability, and carcinogenesis.
Cousineau I; Abaji C; Belmaaza A
Cancer Res; 2005 Dec; 65(24):11384-91. PubMed ID: 16357146
[TBL] [Abstract][Full Text] [Related]
13. LSD1 engages a corepressor complex for the activation of the estrogen receptor α by estrogen and cAMP.
Bennesch MA; Segala G; Wider D; Picard D
Nucleic Acids Res; 2016 Oct; 44(18):8655-8670. PubMed ID: 27325688
[TBL] [Abstract][Full Text] [Related]
14. ERα Mediates Estrogen-Induced Expression of the Breast Cancer Metastasis Suppressor Gene BRMS1.
Ma H; Gollahon LS
Int J Mol Sci; 2016 Jan; 17(2):. PubMed ID: 26821020
[TBL] [Abstract][Full Text] [Related]
15. Association of FGFR1 with ERα Maintains Ligand-Independent ER Transcription and Mediates Resistance to Estrogen Deprivation in ER
Formisano L; Stauffer KM; Young CD; Bhola NE; Guerrero-Zotano AL; Jansen VM; Estrada MM; Hutchinson KE; Giltnane JM; Schwarz LJ; Lu Y; Balko JM; Deas O; Cairo S; Judde JG; Mayer IA; Sanders M; Dugger TC; Bianco R; Stricker T; Arteaga CL
Clin Cancer Res; 2017 Oct; 23(20):6138-6150. PubMed ID: 28751448
[No Abstract] [Full Text] [Related]
16. Estrogen Receptor-β Modulation of the ERα-p53 Loop Regulating Gene Expression, Proliferation, and Apoptosis in Breast Cancer.
Lu W; Katzenellenbogen BS
Horm Cancer; 2017 Aug; 8(4):230-242. PubMed ID: 28577282
[TBL] [Abstract][Full Text] [Related]
17. KMT2C mediates the estrogen dependence of breast cancer through regulation of ERα enhancer function.
Gala K; Li Q; Sinha A; Razavi P; Dorso M; Sanchez-Vega F; Chung YR; Hendrickson R; Hsieh JJ; Berger M; Schultz N; Pastore A; Abdel-Wahab O; Chandarlapaty S
Oncogene; 2018 Aug; 37(34):4692-4710. PubMed ID: 29755131
[TBL] [Abstract][Full Text] [Related]
18. Dynamics of estrogen-induced ROS and DNA strand break generation in estrogen receptor α-positive breast cancer.
Zhang S; Shang P; Gao K; Zhao G; Zhou J; Chen R; Ning X; Guo C
Biochem Biophys Res Commun; 2022 Apr; 602():170-178. PubMed ID: 35278890
[TBL] [Abstract][Full Text] [Related]
19. Different epigenetic mechanisms of ERα implicated in the fate of fulvestrant-resistant breast cancer.
Tsuboi K; Kaneko Y; Nagatomo T; Fujii R; Hanamura T; Gohno T; Yamaguchi Y; Niwa T; Hayashi SI
J Steroid Biochem Mol Biol; 2017 Mar; 167():115-125. PubMed ID: 27888136
[TBL] [Abstract][Full Text] [Related]
20. Prolonged exposure to particulate chromate inhibits RAD51 nuclear import mediator proteins.
Browning CL; Wise JP
Toxicol Appl Pharmacol; 2017 Sep; 331():101-107. PubMed ID: 28554658
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
